Abiopharma

Cassava Reports Q3 2025 Financials Results and Provides Business Update

Silence Therapeutics to Participate in Fireside Chat at Jefferies Global Healthcare Conference

Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine in Schizophrenia from the RECOVER 12-month Open Label Extension Trial at Neuroscience 2025

Alto Neuroscience, Inc. - Alto Neuroscience Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Alto Neuroscience Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

MOVE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Movano Inc. is Fair to Shareholders

Cybin - Cybin to Participate in the Jefferies Global Healthcare Conference in London

Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates

Cybin to Participate in the Jefferies Global Healthcare Conference in London